Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in the female and male genital tract: localization, biosynthesis, and functional and clinical significance
- PMID: 7755080
- DOI: 10.1016/0002-9378(95)90506-5
Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in the female and male genital tract: localization, biosynthesis, and functional and clinical significance
Abstract
Vasoactive intestinal polypeptide, a neuropeptide with wide distribution in the central and peripheral nervous system, has a broad spectrum of biologic actions. The demonstration of vasoactive intestinal polypeptide containing nerve fibers within the female and male genital tract 17 years ago indicated a putative role for this peptide in the local nervous control of reproductive functions. The genes encoding the preprovasoactive intestinal polypeptide precursor molecule and the vasoactive intestinal polypeptide receptor have been identified. The gene expression has been studied by the use of specific antibodies against the functional domains of the vasoactive intestinal polypeptide precursor and the biologic action elucidated by both in vivo and in vitro methods. Evidence has been provided to support vasoactive intestinal polypeptide as a neurotransmitter in several physiologic events in the genital tracts (i.e., blood flow and nonvascular smooth muscle relaxation). In the ovary vasoactive intestinal polypeptide seems to play an important role as regulator and/or modulator of folliculogenesis and steroidogenesis. In the male genital tract vasoactive intestinal polypeptide seems to participate in the control of erection. Vasoactive intestinal polypeptide has been suggested as a causative factor in some diseases of the genital organs (e.g., it may play a pathophysiologic role in male impotence and the peptide is currently used in the treatment of this condition). Vasoactive intestinal polypeptide may be important for control of the low resistance in the fetomaternal vascular bed and is therefore a putative factor involved in the development of preeclampsia. The therapeutic potential of vasoactive intestinal polypeptide and future agonists and antagonists will be revealed by ongoing and forthcoming studies.
Similar articles
-
Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.Am J Obstet Gynecol. 1983 Sep 15;147(2):208-24. doi: 10.1016/0002-9378(83)90117-5. Am J Obstet Gynecol. 1983. PMID: 6137145 Review.
-
Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection.Life Sci. 1983 Jul 25;33(4):383-91. doi: 10.1016/s0024-3205(83)80013-7. Life Sci. 1983. PMID: 6410140
-
Distribution of vasoactive intestinal polypeptide binding sites in guinea pig genital tissues.Neurosci Lett. 1987 Oct 16;81(1-2):111-6. doi: 10.1016/0304-3940(87)90349-1. Neurosci Lett. 1987. PMID: 2827063
-
Vasoactive intestinal polypeptide and the reproductive system.Ann N Y Acad Sci. 1988;527:393-404. doi: 10.1111/j.1749-6632.1988.tb26995.x. Ann N Y Acad Sci. 1988. PMID: 3291695 Review. No abstract available.
-
Vasoactive intestinal polypeptide (VIP): current status.Peptides. 1984 Mar-Apr;5(2):143-50. doi: 10.1016/0196-9781(84)90197-9. Peptides. 1984. PMID: 6147814 Review.
Cited by
-
Colocalisation of neuropeptides, nitric oxide synthase and immunomarkers for catecholamines in nerve fibres of the adult human vas deferens.J Anat. 1999 Nov;195 ( Pt 4)(Pt 4):481-9. doi: 10.1046/j.1469-7580.1999.19540481.x. J Anat. 1999. PMID: 10634688 Free PMC article.
-
Bisphenol A affects vipergic nervous structures in the porcine urinary bladder trigone.Sci Rep. 2021 Jun 9;11(1):12147. doi: 10.1038/s41598-021-91529-0. Sci Rep. 2021. PMID: 34108533 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources